-Universitätsklinikder

[11] Bhatnagar, S., Mishra, S., Roshni, S., Gogia, V., Khanna, S. (2010).
Neuropathic pain in cancer patients--prevalence and management in a
tertiary care anesthesia-run referral clinic based in urban India. J Palliat
Med 13 (7), 819–824
[12] Bradley, N., Davis, L., Chow, E. (2005). Symptom distress in patients
attending an outpatient palliative radiotherapy clinic. J Pain Symptom
Manage 30 (2), 123–131
[13] Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B.,
Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., Konstam, M. A.,
Baron, J. A. (2005). Cardiovascular events associated with rofecoxib in a
colorectal adenoma chemoprevention trial. N. Engl. J. Med. 352 (11),
1092–1102
[14] Brkljacić Zagrović, M. (2010). Palliative medicine--linkage of expert human
care for the terminally ill and medical ethics. Acta Med Croatica 64 (4),
263–271
[15] Canal, J., Rosauro, M. J., Pascual, A., Barcelo, A., Santiago, A., Sanchez,
M. A. (2007). 250 PREVALENCE OF NEUROPATHIC PAIN IN CANCER
PATIENTS. European Journal of Pain 11 (1), 110–110
[16] Cancer pain relief and palliative care. Report of a WHO Expert Committee.
(1990). World Health Organ Tech Rep Ser 804, 1–75
[17] Caraceni, A., Portenoy, R. K. (1999). An international survey of cancer pain
characteristics and syndromes. PAIN 82 (3), 263–274
[18] Carson, J. L., Strom, B. L., Soper, K. A., West, S. L., Morse, M. L. (1987).
The association of nonsteroidal anti-inflammatory drugs with upper
gastrointestinal tract bleeding. Arch. Intern. Med. 147 (1), 85–88
[19] Cervero, F. (1991). Mechanisms of acute visceral pain. Br. Med. Bull. 47
(3), 549–560
[20] Cherny, N. I., Portenoy, R. K., Raber, M., Zenz, M. (1994). Drug therapy for
tumor pain I. Properties of non-opioids and opioids. Schmerz 8 (4), 195–
209
63